304 related articles for article (PubMed ID: 29134827)
21. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
22. Salivary protein biomarkers for head and neck cancer.
Amenábar JM; Da Silva BM; Punyadeera C
Expert Rev Mol Diagn; 2020 Mar; 20(3):305-313. PubMed ID: 31986927
[No Abstract] [Full Text] [Related]
23. Tumor DNA: an emerging biomarker in head and neck cancer.
Bellairs JA; Hasina R; Agrawal N
Cancer Metastasis Rev; 2017 Sep; 36(3):515-523. PubMed ID: 28801876
[TBL] [Abstract][Full Text] [Related]
24. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers.
Drake RR; Cazare LH; Semmes OJ; Wadsworth JT
Expert Rev Mol Diagn; 2005 Jan; 5(1):93-100. PubMed ID: 15723595
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
26. RNA-Based Liquid Biopsy in Head and Neck Cancer.
Kabzinski J; Kucharska-Lusina A; Majsterek I
Cells; 2023 Jul; 12(14):. PubMed ID: 37508579
[TBL] [Abstract][Full Text] [Related]
27. Liquid Biopsy in Oral Cancer.
Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
[TBL] [Abstract][Full Text] [Related]
28. Protein biomarker discovery for head and neck cancer.
Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
[TBL] [Abstract][Full Text] [Related]
29. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
30. Salivary miR-93 and miR-200a as post-radiotherapy biomarkers in head and neck squamous cell carcinoma.
Greither T; Vorwerk F; Kappler M; Bache M; Taubert H; Kuhnt T; Hey J; Eckert AW
Oncol Rep; 2017 Aug; 38(2):1268-1275. PubMed ID: 28677748
[TBL] [Abstract][Full Text] [Related]
31. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
32. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma.
Chan JYK; Zhen G; Agrawal N
Semin Cancer Biol; 2019 Apr; 55():1-7. PubMed ID: 30082187
[TBL] [Abstract][Full Text] [Related]
33. Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids - the state of art.
Ribeiro IP; de Melo JB; Carreira IM
Mol Cytogenet; 2019; 12():33. PubMed ID: 31333762
[TBL] [Abstract][Full Text] [Related]
34. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers.
Lim Y; Wan Y; Vagenas D; Ovchinnikov DA; Perry CF; Davis MJ; Punyadeera C
BMC Cancer; 2016 Sep; 16(1):749. PubMed ID: 27663357
[TBL] [Abstract][Full Text] [Related]
35. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma.
Almadori G; Bussu F; Galli J; Limongelli A; Persichilli S; Zappacosta B; Minucci A; Paludetti G; Giardina B
Head Neck; 2007 Jul; 29(7):648-54. PubMed ID: 17274058
[TBL] [Abstract][Full Text] [Related]
36. Saliva as a potential non-invasive liquid biopsy for early and easy diagnosis/prognosis of head and neck cancer.
Kumar P; Gupta S; Das BC
Transl Oncol; 2024 Feb; 40():101827. PubMed ID: 38042138
[TBL] [Abstract][Full Text] [Related]
37. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
38. Liquid Biopsy: A Future Tool for Posttreatment Surveillance in Head and Neck Cancer?
van Ginkel JH; Huibers MMH; Noorlag R; de Bree R; van Es RJJ; Willems SM
Pathobiology; 2017; 84(3):115-120. PubMed ID: 27974721
[TBL] [Abstract][Full Text] [Related]
39. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
[TBL] [Abstract][Full Text] [Related]
40. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
